Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma
Open Access
- 1 March 2002
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 138 (3) , 325-332
- https://doi.org/10.1001/archderm.138.3.325
Abstract
CUTANEOUS T-cell lymphoma (CTCL) is a heterogeneous group of low-grade non-Hodgkin lymphomas that manifest primarily in the skin.1 Mean age at onset of disease is 50 to 56 years, and it is more common in men than in women (2.2:1.0) and in blacks than in whites (2:1).2,3 Approximately 1000 or more new cases of CTCL are diagnosed each year in the United States. The cause is unknown.3Keywords
This publication has 13 references indexed in Scilit:
- Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacyJournal of the American Academy of Dermatology, 2001
- Primary Cutaneous T-Cell Lymphoma: Review and Current ConceptsJournal of Clinical Oncology, 2000
- Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patientsPublished by Elsevier ,1999
- ADVANCES IN THE MANAGEMENT OF CUTANEOUS T-CELL LYMPHOMADermatologic Clinics, 1998
- Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysisArchives of Dermatology, 1996
- Activation of Retinoid X Receptors Induces Apoptosis in HL-60 Cell LinesMolecular and Cellular Biology, 1995
- Calcipotriene ointment 0.005% for psoriasis: A safety and efficacy studyJournal of the American Academy of Dermatology, 1995
- Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatmentCA: A Cancer Journal for Clinicians, 1993
- Mycosis fungoides and the Sézary syndrome: Pathology, staging, and treatmentCurrent Problems in Cancer, 1990
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989